Abstract
The present study includes 70 healthy, immediately postmenopausal women stratified according to future rate of bone loss. The stratification was performed by means of four parameters of bone turnover: serum alkaline phosphatase, fasting urinary calcium and hydroxyproline, and body weight, used in an equation developed in a previous study. After the stratification the women were followed without intervention for the next 24 months, with bone mass measurements every 3 months. The bone loss estimated at baseline by means of the equation correlated with the bone loss measured in the forearm (y=0.72x−1.52;r=0.61;P<0.001). Plasma bone gla protein (BGP, osteocalcin), which is a new specific marker of bone formation, was now added to the model (replacing body weight). This increased the diagnostic validity (y=x;r=0.76;P<0.001). From the present study we conclude that the postmenopausal bone loss can be predicted by means of four biochemical parameters determined in plasma and urine in women just after the menopause.
Similar content being viewed by others
References
Cummings ST, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fracture. Epidemiol Rev 1985; 7: 178–208.
Hui SL, Slemenda CW, Johnston C, Appledorn CR. Effects of age and menopause on vertebral bone density. Bone Miner 1987; 2: 141–6.
Nilas L, Christiansen C. Bone mass and its relationship to age and the menopause. J Clin Endocrinol Metab 1987; 65: 697–702.
Riis B, Thomsen K, Christiansen C. Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. N Engl J Med 1987; 316: 173–7.
Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund K-E, Transbøl I. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 1980; 10: 273–9.
Lindsay R, Aitken JM, Anderson JB et al. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1976; i: 1038–40.
Christiansen C, Christensen MS, Transbøl I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981; i: 459–61.
Mack TM, Pike MC, Henderson BE et al. Estrogens and endometrial cancer in a retirement community. N Engl J Med 1976; 294: 1262–7.
Persson I, Adami H-O, Bergkvist L et al. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. Br Med J 1989; 298: 147–151.
Hirvonen E, Mälkönen M, Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med 1981; 304: 560–3.
Reginster JY, Albert A, Lecart MP et al. 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 1987; ii: 1481–3.
Overgaard K, Riis BJ, Christiansen C, Hansen MA. Effect of salcatonin given intranasally on early postmenopausal bone loss. Br Med J 1989; 299: 477–9.
Ott SM, Kilcoyne RF, Chesnut III CH. Longitudinal changes in bone mass after one year as measured by different techniques in patients with osteoporosis. Calcif Tissue Int 1986; 39: 133–8.
Riis BJ, Christiansen C. Measurement of spinal or peripheral bone mass to estimate early postmenopausal bone loss? Am J Med 1988; 84: 646–53.
Johansen JS, Riis BJ, Delmas PD, Christiansen C. Plasma BGP: An indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women. Eur J Clin Invest 1988; 18: 191–5.
Christiansen C, Riis BJ, Rødbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987; i: 1105–8.
Christiansen C. Selection of postmenopausal women for estrogen therapy. In: Christiansen C, Johansen J, Riis BJ, eds. Osteoporosis 1987. Proceedings of the international symposium on osteoporosis, Denmark 1987. Copenhagen: Osteopress, ApS, 1987; 533–8.
Nilas L, Borg J, Gotfredsen A, Christiansen C. Comparison of single- and dual-photon absorptiometry in postmenopausal bone mineral loss. J Nucl Med 1985; 26: 1257–62.
Nilas L, Hassager C, Christiansen C. Long-term precision of dual-photon absorptiometry in the lumbar spine in clinical settings. Bone Miner 1988; 3: 305–15.
Gotfredsen A, Borg J, Christiansen C, Mazess RB. Total body bone mineral in vivo by dual-photon absorptiometry. I. Measurement procedures. Clin Physiol 1984; 4: 343–55.
Boddy K, King PC, Hume R, Weyers E. The relation of total body potassium to height, weight, and age in normal adults. J Clin Pathol 1972; 25: 512–7.
Hassager C, Gotfredsen A, Jensen J, Christiansen C. Prediction of body composition by age, height, weight, and skinfold thickness in normal adults. Metabolism 1986; 35: 1081–4.
Johansen JS, Hansen JEM, Christiansen C. A radioimmunoassay for bone gla-protein (BGP) in human plasma. Acta Endocrinol 1987; 114: 410–6.
Pødenphant J, Larsen N-E, Christiansen C. An easy and reliable method for determination of urinary hydroxyproline. Clin Chim Acta 1984; 142: 145–8.
Slemenda C, Hui SL, Longcope C, Johnston CC. Sex steroids and bone mass. J Clin Invest 1987; 80: 1261–9.
Civitelli R, Gonnelli S, Zacchei F et al. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest 1988; 82: 1268–74.
Ross PD, Wasnich RD, Vogel JM. Precision error in dual-photon absorptiometry related to source age. Radiology 1988; 166: 523–7.
Riis BJ, Rødbro P, Christiansen C. The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis. Calcif Tissue Int 1986; 38: 318–22.
Riggs BL, Mann KG. Assessment of bone turnover in osteoporosis using biochemical markers. In: Christiansen C, Johansen JK, Riis BJ, eds. Osteoporosis 1987. Proceedings of the international symposium on osteoporosis, Denmark 1987. Copenhagen: Osteopress ApS, 1987; 672–6.
Pødenphant J, Johansen JS, Thomsen K, Riis BJ, Leth A, Christiansen C. Bone turnover in spinal osteoporosis. J Bone Min Res 2: 497–503.
Jensen GF, Christiansen C, Transbøl I. Fracture frequency and bone preservation in postmenopausal women treated with oestrogen. Obstet Gynecol 1982; 60: 493–6.
Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy. I. A 10-year prospective study in the releationship to osteoporosis. Obstet Gynecol 1979; 53: 277–81.
Lindsay R, Hart DM, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980; ii: 1151–4.
Delmas PD, Christiansen C, Mann KG, Price PA. Bone gla-protein (osteocalcin) assay standardization report. J Bone Min Res 1990; 5: 5–11.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Christiansen, C., Riis, B.J. & Rødbro, P. Screening procedure for women at risk of developing postmenopausal osteoporosis. Osteoporosis Int 1, 35–40 (1990). https://doi.org/10.1007/BF01880414
Issue Date:
DOI: https://doi.org/10.1007/BF01880414